The Veteran was granted a 60 percent disability rating for his skin disability and a separate 10 percent rating for scarring of bilateral facial cheeks due to chloracne, effective July 14, 2022.
The deciding factor: The Veteran's treatment required constant or near-constant systemic therapy, which meets the criteria for a 60 percent rating under the General Rating Formula for the Skin. The presence of one characteristic of disfigurement also supports a separate 10 percent rating for scarring of bilateral facial cheeks.
- Claimed conditions
- chloracne, scarring of bilateral facial cheeks due to chloracne
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- March 26, 2025
- Citation
- A25028361
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for further development, including obtaining additional medical opinions and private treatment records.
- Partly granted
The appeal for readjudication of the claim of entitlement to service connection for vision loss has been withdrawn.,Readjudication of the claim for entitlement to service connection for asthma is granted, as new and relevant evidence has been received.,Readjudication of the claim for entitlement to service connection for hypertension is granted, as new and relevant evidence has been received.,Readjudication of the claim for entitlement to service connection for loss of taste (ageusia) and loss of smell (anosmia) is granted, as new and relevant evidence has been received.,The claim for entitlement to service connection for chloracne, to include as secondary to in-service herbicide exposure, is denied, as new and relevant evidence has not been received.,Entitlement to service connection for hypertension is granted pursuant to the PACT Act.
- Denied
The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several other claims.
- Denied
The Board denied the Veteran's claim for service connection for chloracne, finding no current disability and insufficient evidence of in-service exposure or a link to service.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.